Retarded Onchocerca volvulus L1 to L3 larval development in the Simulium damnosum vector after anti-wolbachial treatment of the human host
- PMID: 22236497
- PMCID: PMC3311148
- DOI: 10.1186/1756-3305-5-12
Retarded Onchocerca volvulus L1 to L3 larval development in the Simulium damnosum vector after anti-wolbachial treatment of the human host
Abstract
Background: The human parasite Onchocerca volvulus harbours Wolbachia endosymbionts essential for worm embryogenesis, larval development and adult survival. In this study, the development of Wolbachia-depleted microfilariae (first stage larvae) to infective third stage larvae (L3) in the insect vector Simulium damnosum was analysed.
Methods: Infected volunteers in Cameroon were randomly and blindly allocated into doxycycline (200 mg/day for 6 weeks) or placebo treatment groups. After treatment, blackflies were allowed to take a blood meal on the volunteers, captured and dissected for larval counting and DNA extraction for quantitative real-time PCR analysis.
Results: PCR results showed a clear reduction in Wolbachia DNA after doxycycline treatment in microfilariae from human skin biopsies with > 50% reduction at one month post-treatment, eventually reaching a reduction of > 80%. Larval stages recovered from the insect vector had similar levels of reduction of endosymbiotic bacteria. Larval recoveries were analysed longitudinally after treatment to follow the kinetics of larval development. Beginning at three months post-treatment, significantly fewer L3 were seen in the blackflies that had fed on doxycycline treated volunteers. Concomitant with this, the proportion of second stage larvae (L2) was significantly increased in this group.
Conclusions: Doxycycline treatment and the resulting decline of Wolbachia endobacteria from the microfilaria resulted in retarded development of larvae in the insect vector. Thus, anti-wolbachial treatment could have an additive effect for interrupting transmission by reducing the number of L3 that can be transmitted by blackflies.
© 2012 Albers et al; licensee BioMed Central Ltd.
Figures


Similar articles
-
Development by injection in Simulium damnosum s.l. of two Onchocerca species from the wart hog to infective larvae resembling type D larvae (Duke, 1967).Parasite. 1995 Mar;2(1):55-62. doi: 10.1051/parasite/1995021055. Parasite. 1995. PMID: 9137644
-
Onchocerca ochengi: morphological identification of the L3 in wild Simulium damnosum s.l., verified by DNA probes.Parasitology. 1998 Apr;116 ( Pt 4):337-48. doi: 10.1017/s0031182097002321. Parasitology. 1998. PMID: 9585936
-
Efficacy of 2- and 4-week rifampicin treatment on the Wolbachia of Onchocerca volvulus.Parasitol Res. 2008 Nov;103(6):1303-9. doi: 10.1007/s00436-008-1133-y. Epub 2008 Aug 5. Parasitol Res. 2008. PMID: 18679718 Clinical Trial.
-
Doxycycline in the treatment of human onchocerciasis: Kinetics of Wolbachia endobacteria reduction and of inhibition of embryogenesis in female Onchocerca worms.Microbes Infect. 2003 Apr;5(4):261-73. doi: 10.1016/s1286-4579(03)00026-1. Microbes Infect. 2003. PMID: 12706439 Clinical Trial.
-
Factors affecting onchocerciasis transmission: lessons for infection control.Expert Rev Anti Infect Ther. 2017 Apr;15(4):377-386. doi: 10.1080/14787210.2017.1286980. Epub 2017 Feb 3. Expert Rev Anti Infect Ther. 2017. PMID: 28117596 Review.
Cited by
-
Application of loop mediated isothermal amplification (LAMP) assays for the detection of Onchocerca volvulus, Loa loa and Mansonella perstans in humans and vectors.Front Trop Dis. 2023 Jan 9;3:1016176. doi: 10.3389/fitd.2022.1016176. Front Trop Dis. 2023. PMID: 36684508 Free PMC article.
-
Development of a High-Throughput Cytometric Screen to Identify Anti- Wolbachia Compounds: The Power of Public-Private Partnership.SLAS Discov. 2019 Jun;24(5):537-547. doi: 10.1177/2472555219838341. Epub 2019 Apr 8. SLAS Discov. 2019. PMID: 30958712 Free PMC article.
-
Discovery of ABBV-4083, a novel analog of Tylosin A that has potent anti-Wolbachia and anti-filarial activity.PLoS Negl Trop Dis. 2019 Feb 28;13(2):e0007159. doi: 10.1371/journal.pntd.0007159. eCollection 2019 Feb. PLoS Negl Trop Dis. 2019. PMID: 30818326 Free PMC article.
-
Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis.Sci Rep. 2017 Mar 16;7(1):210. doi: 10.1038/s41598-017-00322-5. Sci Rep. 2017. PMID: 28303006 Free PMC article.
-
Albendazole and antibiotics synergize to deliver short-course anti-Wolbachia curative treatments in preclinical models of filariasis.Proc Natl Acad Sci U S A. 2017 Nov 7;114(45):E9712-E9721. doi: 10.1073/pnas.1710845114. Epub 2017 Oct 23. Proc Natl Acad Sci U S A. 2017. PMID: 29078351 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical